Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Combination of ultra-low-dose isotretinoin and antihistamines in treating Morbihan disease – a new long-term approach with excellent results and a minimum of side effects
By
- AMS
posted
Feb 05, 2020 02:56 AM
0
Recommend
Volume 32, Issue 8
, December 2021, Page 941-944
.
0 comments
0 views
Related Content
Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites
- AMS
Added Mar 06, 2020
Blog Entry
Long-term outcomes of crystallized phenol application for the treatment of pilonidal sinus disease
- AMS
Added Oct 20, 2020
Blog Entry
A survey of long-term results with microwave energy device for treating axillary hyperhidrosis
- AMS
Added Aug 19, 2021
Blog Entry
Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis
- AMS
Added Jul 30, 2021
Blog Entry
Effect of isotretinoin (13-cis-retinoic acid) on levels of soluble VEGF receptors (sVEGFR1, sVEGFR2, sVEGFR3) in patients with acne vulgaris
- AMS
Added Feb 20, 2020
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic